| Trial ID: | L3631 |
| Source ID: | NCT02612714
|
| Associated Drug: |
Rosuvastatin
|
| Title: |
Statin Lowering Testosterone and Sexual Function
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Sexual Dysfunction
|
| Interventions: |
DRUG: Rosuvastatin
|
| Outcome Measures: |
Primary: serum testosterone, The measure is a composite outcome measure consisting of multiple measures. Serum testosterone measured after 24 weeks statin treatment, after quitted statin for 24 weeks and after 24 weeks of re-administrating statin, up to 24 weeks | Secondary: sexual function evaluation, The measure is a composite outcome measure consisting of multiple measures. Sexual function measured by questionaire after 24 weeks of statin treatment, after quitted statin for 24 weeks and after 24 weeks of re-administrating statin, up to 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Chang Gung Memorial Hospital
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
151
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2013-07
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2015-11-24
|
| Locations: |
Chang Gung, Kaohsiung, 83349, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT02612714
|
